Trinity Biotech (TRIB) EBT Margin (2009 - 2024)
Trinity Biotech recorded quarterly EBT Margin of 99.62% in Q4 2024, down 214.87% quarter-over-quarter from 31.64% in Q3 2024, and down 5863.0% year-over-year from 1.73% in Q1 2024.
Trinity Biotech's EBT Margin history runs 16 years deep, the most recent figure standing at 99.62% for Q4 2024.
- In Q4 2024, EBT Margin fell 5863.0% year-over-year to 99.62%; the TTM figure through Dec 2024 stood at 49.92% (up 1506.0% YoY), while the FY2025 annual figure was 84.91%, down 3499.0% from the prior year.
- EBT Margin came in at 99.62% for Q4 2024 at Trinity Biotech, down from 31.64% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 32.17% in Q3 2020 to a low of 133.93% in Q2 2023.
- A 5-year average of 31.97% and a median of 36.32% in 2024 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin tumbled 10109 bps in 2022 and surged 9045 bps in 2024, its largest moves.
- Trinity Biotech's EBT Margin stood at 31.41% in 2020, then slumped by 140 bps to 12.44% in 2021, then slumped by 433 bps to 66.32% in 2022, then surged by 38 bps to 41.0% in 2023, then sank by 143 bps to 99.62% in 2024.
- According to Business Quant data, EBT Margin over the past three periods registered 99.62%, 31.64%, and 43.48% for Q4 2024, Q3 2024, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 15.57% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 27.84% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.87% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 22.61% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.84% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.17% |
| 10 | Trinity Biotech | 28,000.00 | -5.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -99.62% |
| Sep 30, 2024 | -31.64% |
| Jun 30, 2024 | -43.48% |
| Mar 31, 2024 | -22.10% |
| Dec 31, 2023 | -41.00% |
| Sep 30, 2023 | -44.27% |
| Jun 30, 2023 | -133.93% |
| Mar 31, 2023 | -42.59% |
| Dec 31, 2022 | -66.32% |
| Sep 30, 2022 | -63.59% |
| Jun 30, 2022 | -65.84% |
| Mar 31, 2022 | -84.34% |
| Dec 31, 2021 | -12.44% |
| Sep 30, 2021 | 7.28% |
| Jun 30, 2021 | -0.50% |
| Mar 31, 2021 | 16.75% |
| Dec 31, 2020 | 31.41% |
| Sep 30, 2020 | 32.17% |
| Jun 30, 2020 | 10.75% |
| Mar 31, 2020 | 13.81% |
| Dec 31, 2019 | 12.59% |
| Sep 30, 2019 | 10.40% |
| Jun 30, 2019 | 10.85% |
| Mar 31, 2019 | 11.64% |
| Dec 31, 2018 | 11.94% |
| Sep 30, 2018 | 9.69% |
| Jun 30, 2018 | 11.54% |
| Mar 31, 2018 | 12.46% |
| Dec 31, 2017 | 8.09% |
| Sep 30, 2017 | 10.53% |
| Jun 30, 2017 | 11.79% |
| Mar 31, 2017 | 10.53% |
| Dec 31, 2016 | -180.92% |
| Sep 30, 2016 | -1.41% |
| Jun 30, 2016 | 8.50% |
| Mar 31, 2016 | -4.95% |
| Dec 31, 2015 | 12.23% |
| Sep 30, 2015 | 48.92% |
| Jun 30, 2015 | 12.00% |
| Mar 31, 2015 | 17.08% |
| Dec 31, 2014 | 16.16% |
| Sep 30, 2014 | 17.07% |
| Jun 30, 2014 | 17.65% |
| Mar 31, 2014 | 18.09% |
| Dec 31, 2013 | 19.52% |
| Sep 30, 2013 | 20.69% |
| Jun 30, 2013 | 19.27% |
| Mar 31, 2013 | 21.36% |
| Dec 31, 2012 | 23.51% |
| Sep 30, 2012 | 23.60% |
| Jun 30, 2012 | 23.38% |
| Mar 31, 2012 | 23.35% |
| Dec 31, 2011 | 23.49% |
| Sep 30, 2011 | 23.43% |
| Jun 30, 2011 | 23.21% |
| Mar 31, 2011 | 23.25% |
| Dec 31, 2010 | 21.14% |
| Sep 30, 2010 | 16.67% |
| Jun 30, 2010 | 224.18% |
| Mar 31, 2010 | 11.87% |
| Dec 31, 2009 | 10.48% |
| Sep 30, 2009 | 10.86% |
| Jun 30, 2009 | 10.81% |
| Mar 31, 2009 | 8.85% |